Juxtapid Side Effects

Generic name: lomitapide

Medically reviewed by Drugs.com. Last updated on Sep 15, 2024.

Note: This document provides detailed information about Juxtapid Side Effects associated with lomitapide. Some dosage forms listed on this page may not apply specifically to the brand name Juxtapid.

Applies to lomitapide: oral capsule.

Important warnings This medicine can cause some serious health issues

Oral route (capsule)

Lomitapide mesylate can cause elevations in transaminases.

Measure ALT, AST, alkaline phosphatase, and total bilirubin before initiating treatment and then ALT and AST regularly as recommended.

During treatment, adjust the dose of lomitapide mesylate if the ALT or AST is 3 times the ULN or greater.

Discontinue lomitapide mesylate for clinically significant liver toxicity.

Lomitapide mesylate increases hepatic fat (hepatic steatosis) with or without concomitant increases in transaminases.

Hepatic steatosis associated with lomitapide mesylate may be a risk factor for progressive liver disease, including steatohepatitis and cirrhosis.

Because of the risk of hepatotoxicity, lomitapide mesylate is available only through a restricted program called the Juxtapid® REMS Program.

Prescribe lomitapide mesylate only to patients with a clinical or laboratory diagnosis consistent with homozygous familial hypercholesterolemia (HoFH).

The safety and effectiveness of lomitapide mesylate have not been established in patients with hypercholesterolemia who do not have HoFH.

Serious side effects of Juxtapid

Along with its needed effects, lomitapide (the active ingredient contained in Juxtapid) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking lomitapide:

More common side effects

• arm, back, or jaw pain
• chest pain or discomfort
• chest tightness or heaviness
• dark urine
• fast, irregular, pounding, or racing heartbeat or pulse
• fever
• light-colored stools
• loss of appetite
• nausea and vomiting
• sweating
• trouble breathing
• unusual tiredness or weakness
• upper right abdominal or stomach pain
• yellow eyes and skin

Other side effects of Juxtapid

Some side effects of lomitapide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common side effects

• acid or sour stomach
• back pain
• belching
• chills
• constipation
• cough
• decreased weight
• diarrhea
• dizziness
• excess air or gas in the stomach or intestines
• frequent urge to defecate
• full or bloated feeling
• general feeling of discomfort or illness
• headache
• heartburn
• indigestion
• joint pain
• muscle aches and pains
• passing gas
• pressure in the stomach
• shivering
• sore throat
• stomach discomfort, upset, or pain
• straining while passing stool
• stuffy or runny nose
• sweating
• swelling of the abdominal or stomach area
• trouble sleeping
• weakness

Incidence not known

• hair loss or thinning of the hair

For healthcare professionals

Applies to lomitapide: oral capsule.

Cardiovascular adverse events

• Very common (10% or more): Chest pain (24%), angina pectoris (10%), palpitations (10%)^[Ref]

Gastrointestinal

• Very common (10% or more): Diarrhea (79%), nausea (65%), dyspepsia (38%), vomiting (34%), abdominal pain (34%), abdominal discomfort (21%), abdominal distention (21%), constipation (21%), flatulence (21%), gastroesophageal reflux disease (10%), defecation urgency ((10%), rectal tenesmus (10%), gastroenteritis (14%)^[Ref]

Hepatic

• Very common (10% or more): Increased ALT (17%), at least one elevation in ALT and/or AST greater than or equal to 3 times ULN (29%), hepatic steatosis: of 23 patients in a study for 78 weeks, 18 (78%) exhibited an increase in hepatic fat greater than 5% and 3 (13%) exhibited an increase greater than 20%^[Ref]

Immunologic

• Very common (10% or more): Influenza (21%)^[Ref]

Metabolic

• Very common (10% or more): Weight loss (24%)^[Ref]

Nervous system

• Very common (10% or more): Fatigue (17%), fever (10%), headache (10%), dizziness (10%)^[Ref]

Respiratory

• Very common (10% or more): Nasopharyngitis (17%), pharyngolaryngeal pain (14%), nasal congestion (10%)^[Ref]

Dermatologic

• Common (1% to 10%): Ecchymosis, papule, rash erythematous, xanthoma^[Ref]

Frequently asked questions

• Is Juxtapid FDA-approved as a high cholesterol treatment?
• What is the mechanism of action for Juxtapid (lomitapide)?

Further information

Juxtapid side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer